Patents by Inventor Seong-Who KIM

Seong-Who KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STEM CELL IN WHICH IMMUNE CELL TOLERANCE MODULATOR IS OVEREXPRESSED, AND USE THEREOF
    Publication number: 20240115614
    Abstract: A method for treating a cell damage-related disease, including administering a composition to a subject in need thereof. The composition contains, as an active ingredient, one or more selected from the group consisting of stem cells genetically engineered to overexpress a carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family protein, cells differentiated from the stem cells, and components derived from the stem cells.
    Type: Application
    Filed: January 14, 2022
    Publication date: April 11, 2024
    Applicants: THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Hun Sik KIM, Seong Who KIM, Eunbi YI, Hyojeong KIM, Jung Min KIM, Woo Seon CHOI
  • COMPOSITION FOR PROLIFERATION, DIFFERENTIATION PROMOTION, OR SENESCENCE INHIBITION OF STEM CELLS, CONTAINING JAK1 INHIBITOR AS ACTIVE INGREDIENT
    Publication number: 20190183900
    Abstract: Disclosed is a composition for proliferation, differentiation promotion, and senescence inhibition of stem cells, including a JAK1 inhibitor as an active ingredient, wherein JAK1 inhibitor-treated stem cells or JAK1 knockout stem cells have an activity for decreasing senescence and increasing the survival rate of the stem cells, thereby being usable in a composition for proliferation, differentiation promotion, and senescence inhibition of stem cells.
    Type: Application
    Filed: March 9, 2017
    Publication date: June 20, 2019
    Applicant: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Seong-Who KIM, Sang-Yoon KIM, Hyang-Ju LEE